Tegoprubart

Eledon Pharmaceuticals · AT-1501

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
3 active
8 in total · 2 in the EU
Targets
 

What this is

How it works
CD40 ligand (CD40L) antibody
How it’s given
“AT-1501 20 mg/kg administered every 3 weeks IV + MMF 1000 mg PO twice daily (BID) or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO once daily (QD) or equivalent”In the company’s words, NCT06126380 on ClinicalTrials.gov
Tested for
Kidney Transplant Rejection (2 trials), Prevention of Rejection in Kidney Transplant
Main trialPhase 3
“This study will evaluate the efficacy and safety of tegoprubart compared with tacrolimus in adult participants undergoing first kidney transplantation.”In the company’s words, NCT07835581 on ClinicalTrials.gov
Other names
AT-1501

Other drugs for Kidney Transplant Rejection

All 25 drugs for Kidney Transplant Rejection

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Mar 2029 Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
Phase 2Enrolling by invitation Dec 2029 Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Phase 1/2Recruiting Jan 2027 Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Phase 2Completed 24 Mar 2022 Multiple Doses of AT-1501-A201 in Adults With ALS
Phase 2Terminated 31 Jul 2023 Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
Phase 2Withdrawn Jun 2024 Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation
Phase 2Completed 11 Sep 2025 Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Phase 1/2Withdrawn Aug 2024 Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Tegoprubart

Following is part of Solo: you see every change to Tegoprubart the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in